


【翰宇药业:卡贝缩宫素注射液新适应症获批】财联社7月10日电,翰宇药业公告,公司收到国家药监局核准签发的《药品补充申请批准通知书》,批准卡贝缩宫素注射液增加阴道分娩适应症。
“特别声明:以上作品内容(包括在内的视频、图片或音频)为凤凰网旗下自媒体平台“大风号”用户上传并发布,本平台仅提供信息存储空间服务。
Notice: The content above (including the videos, pictures and audios if any) is uploaded and posted by the user of Dafeng Hao, which is a social media platform and merely provides information storage space services.”